-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $360

Benzinga·07/29/2026 11:55:17
Listen to the news
Barclays analyst Emily Field maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $350 to $360.